EUVIMEDEUVIMED entdecken
Editorial

Real‐World Evidence in Regulatory Decision Making: Time for Evidence Integration

Rebecca A Miksad iD

Clinical Pharmacology & Therapeutics · 2024-11 · 116 (5) · 1153-1155

DOI: 10.1002/cpt.3444 ↗

Kurz gefasst

Editorial in der Zeitschrift Clinical Pharmacology & Therapeutics, online erschienen am 15.10.2024. Verfasst von Rebecca A Miksad. Beteiligte Einrichtung: Boston Medical Center, Boston University, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Decision Making. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 11 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Decision MakingHumansUnited StatesEvidence-Based MedicineUnited States Food and Drug Administration

Autor:innen und Institutionen

  • Boston Medical Center, Boston University, Boston, Massachusetts, USA.
  • Color Health, Burlingame, California, USA.

ORCID-Profile: Rebecca A Miksad

Zitieren

APA

Miksad, R. A. (2024). Real‐World Evidence in Regulatory Decision Making: Time for Evidence Integration. Clinical Pharmacology & Therapeutics, 116(5), 1153-1155. https://doi.org/10.1002/cpt.3444

Vancouver

Miksad RA. Real‐World Evidence in Regulatory Decision Making: Time for Evidence Integration. Clinical Pharmacology & Therapeutics. 2024;116(5):1153-1155. doi:10.1002/cpt.3444

BibTeX
@article{Miksad2024,
  author = {Miksad, Rebecca A},
  title = {Real‐World Evidence in Regulatory Decision Making: Time for Evidence Integration},
  journal = {Clinical Pharmacology & Therapeutics},
  year = {2024},
  volume = {116},
  number = {5},
  pages = {1153--1155},
  doi = {10.1002/cpt.3444}
}
Kostenlos starten →